Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nanovibronix Inc NAOV

NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort... see more

Recent & Breaking News (NDAQ:NAOV)

NanoVibronix Announces Rescheduling of Annual Meeting of Stockholders

Accesswire June 14, 2019

NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield® Designed to Amplify Therapeutic Effect

GlobeNewswire June 5, 2019

NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield(R) Designed to Amplify Therapeutic Effect

Accesswire June 3, 2019

NanoVibronix Provides Business Update for the First Quarter of 2019

Accesswire May 24, 2019

NanoVibronix Provides Year-End Business Update

Accesswire April 2, 2019

NanoVibronix Announces Reimbursement Approvals for PainShield(R) in the U.S.

Accesswire March 25, 2019

NanoVibronix Announces Exclusive Agreement for Distribution of PainShield(R) and UroShield(R) in Italy

Accesswire March 20, 2019

NanoVibronix CEO to Present UroShield(R) at the U.S. National Institutes of Health's Catheter-Associated Urinary Tract Infections Technology Workshop

Accesswire March 8, 2019

NanoVibronix Reports Positive Interim Tennis Elbow Study Results Using PainShield(R)

Accesswire March 7, 2019

NanoVibronix Launches New Consumer and Industry Focused Website Highlighting Advantages of PainShield, UroShield and WoundShield

Accesswire March 4, 2019

NanoVibronix Announces Publication of PainShield™ Trigeminal Neuralgia Study in the Journal of Anesthesiology and Pain Research

GlobeNewswire February 25, 2019

NanoVibronix Enters Collaboration Agreement with Fritz Clinic to Offer PainShield® as an Alternative to Opioids for Pain Management

GlobeNewswire January 11, 2019

NanoVibronix Announces Expanded Agreement with MDS Pharm Ltd. to Include Distribution of UroShield® in Israel

GlobeNewswire December 27, 2018

NanoVibronix Signs Major Distributor in India for UroShield®

GlobeNewswire December 20, 2018

NanoVibronix Signs with Exclusive Distributor in Switzerland for UroShield®

GlobeNewswire December 18, 2018

NanoVibronix Announces Selection of Leading International Contract Manufacturer to Support Rapid Scale-up, Lower Price Points and Enhance Profitability

GlobeNewswire December 11, 2018

NanoVibronix Announces Publication of Study Measuring the Effect of Surface Acoustic Waves on Bacterial Load and Preventing Catheter-Associated Urinary Tract Infections

GlobeNewswire December 6, 2018

New Research: Key Drivers of Growth for Nanovibronix, Griffin Industrial Realty, Iteris, NAPCO Security Technologies, Nortech, and New Age Beverage — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire November 19, 2018

NanoVibronix Provides Business Update for the Third Quarter of 2018

GlobeNewswire November 14, 2018

NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference

GlobeNewswire October 22, 2018